• 1. Evolution of cellulose into flexible conductive green electronics: a smart strategy to fabricate sustainable electrodes for supercapacitors
  Tengfei Yu,Yuehan Wu,Wei Li,Bin Li RSC Adv., 2014,4, 34134-34143
• 2. Enabling non-flammable Li-metal batteries via electrolyte functionalization and interface engineering?
  Jing Yu,Yu-Qi Lyu,Jiapeng Liu,Mohammed B. Effat,Junxiong Wu J. Mater. Chem. A, 2019,7, 17995-18002
• 3. Fast-pulsing NMR techniques for the detection of weak interactions: successful natural abundance probe of hydrogen bonds in peptides?
  Amandine Altmayer-Henzien,Valérie Declerck,David J. Aitken,Ewen Lescop,Denis Merlet,Jonathan Farjon Org. Biomol. Chem., 2013,11, 7611-7615
• 4. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
• 5. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Pyridines and derivatives
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives

Recent Advances in the Study of 4-Bromo-1-methyl-1H-pyrazolo[3,4-c]pyridine (CAS: 1032943-41-1)

4-Bromo-1-methyl-1H-pyrazolo[3,4-c]pyridine (CAS: 1032943-41-1) is a heterocyclic compound that has garnered significant attention in the field of chemical biology and medicinal chemistry due to its potential applications in drug discovery and development. This compound serves as a key intermediate in the synthesis of various biologically active molecules, particularly those targeting protein kinases and other enzymes involved in critical cellular pathways. Recent studies have explored its utility in the design of novel therapeutic agents, with a focus on its structural versatility and reactivity.

One of the most notable advancements in the study of 4-Bromo-1-methyl-1H-pyrazolo[3,4-c]pyridine is its role in the development of kinase inhibitors. Kinases are pivotal in regulating cellular processes such as proliferation, differentiation, and apoptosis, making them attractive targets for cancer therapy. Researchers have successfully utilized this compound as a scaffold to design selective inhibitors for kinases like JAK2 and FLT3, which are implicated in hematologic malignancies. The bromo substituent at the 4-position allows for further functionalization, enabling the introduction of diverse pharmacophores to enhance binding affinity and selectivity.

In addition to its applications in oncology, 4-Bromo-1-methyl-1H-pyrazolo[3,4-c]pyridine has been investigated for its potential in treating inflammatory and autoimmune diseases. Recent studies have demonstrated its efficacy in modulating the activity of immune-related kinases, such as IRAK4 and TAK1, which play crucial roles in inflammatory signaling pathways. These findings highlight the compound's versatility as a building block for the development of small-molecule therapeutics with broad clinical applications.

The synthetic routes to 4-Bromo-1-methyl-1H-pyrazolo[3,4-c]pyridine have also been optimized in recent years, with a focus on improving yield and scalability. Novel methodologies, including transition-metal-catalyzed cross-coupling reactions and microwave-assisted synthesis, have been employed to streamline the production of this compound and its derivatives. These advancements are critical for facilitating its use in high-throughput screening and medicinal chemistry campaigns.

Despite its promising potential, challenges remain in the clinical translation of 4-Bromo-1-methyl-1H-pyrazolo[3,4-c]pyridine-based therapeutics. Issues such as off-target effects, metabolic stability, and bioavailability need to be addressed through further structural optimization and preclinical studies. Nevertheless, the compound's unique chemical properties and biological activities make it a valuable tool for researchers aiming to develop next-generation therapeutics.

In conclusion, 4-Bromo-1-methyl-1H-pyrazolo[3,4-c]pyridine (CAS: 1032943-41-1) represents a versatile and promising scaffold in medicinal chemistry. Its applications span oncology, immunology, and beyond, driven by its ability to serve as a key intermediate in the synthesis of biologically active molecules. Continued research into its synthetic accessibility and therapeutic potential will undoubtedly yield new insights and opportunities for drug discovery.

• 1897500-19-4(6-Bromo-2-methyl-2H-pyrazolo[4,3-b]pyridine)
• 1326715-73-4(3-bromo-1-methyl-pyrazolo[3,4-c]pyridine)
• 1150617-56-3(6-Bromo-1-methyl-1H-pyrazolo[4,3-b]pyridine)
• 1350648-87-1(7-Bromo-2-methyl-2H-pyrazolo[4,3-b]pyridine)
• 1780513-20-3(6-bromo-1-ethyl-1H-pyrazolo[4,3-b]pyridine)
• 1337880-46-2(5-Bromo-1-methyl-1H-pyrazolo[3,4-c]pyridine)
• 1823268-58-1(7-Bromo-1-methyl-pyrazolo[4,3-b]pyridine)
• 2177257-61-1(4-bromo-2-methyl-pyrazolo[3,4-c]pyridine)
• 1367795-99-0(7-Bromo-1-methyl-1H-pyrazolo[4,3-c]pyridine)
• 1032943-43-3(4-Bromo-1H-pyrazolo[3,4-c]pyridine)